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Antimicrobial surfaces for food and medical applications have historically involved antimicrobial
coatings that elute biocides for effective kill in solution or at surfaces. However, recent efforts
have focused on immobilized antimicrobial agents in order to avoid toxicity and the compatibility
and reservoir limitations common to elutable agents. This review critically examines the assorted
antimicrobial agents reported to have been immobilized, with an emphasis on the interpretation of
antimicrobial testing as it pertains to discriminating between eluting and immobilized agents.
Immobilization techniques and modes of antimicrobial action are also discussed.VC 2011 American
Vacuum Society. [DOI: 10.1116/1.3645195]
I. INTRODUCTION
Approximately two million cases of hospital associated
infections (HAIs) occur each year in the United States. These
infections, which involve bacterial, fungal, and viral agents,
contribute to approximately one hundred thousand deaths
annually.1 Bacterial and fungal pathogens often enter
patients via invasive elements employed in supportive meas-
ures such as intubation, intravascular lines, and urinary cathe-
ters.1 The frequency, severity, and cost of HAIs have driven
the development and implementation of increasingly involved
and rigorous aseptic, disinfection, and sterilization procedures.
In addition to improving best aseptic practices in clinical set-
tings, medical device makers are introducing devices with anti-
microbial and antifouling properties as part of overall infection
control technologies designed to help reduce HAIs.2
Medical applications of antimicrobial agents have lever-
aged soluble agents3–7 such as benzalkonium chlorides,
cetylpyridinium chloride, aldehydes, anilides, diamidines,
silver, chlorhexidine, triclosan, N-halamines, and povidone-
iodine. Although such agents are known to be efficacious
and appropriate for specific applications, their extension to
some medical device applications might be hindered by the
elution of the agent, due to a limited reservoir capacity or
potential side effects caused by unwanted exposure. Irrevers-
ible immobilization of the antimicrobial agents in the device
offers an alternative motif that eliminates patient exposure to
elutable active agents and potentially increases the duration
of antimicrobial efficacy.8,9
A wide range of antimicrobial agents have been immobi-
lized, including small molecules (e.g., quaternary ammo-
nium silanes),10–17 quaternary ammonium polymers,18–35
polyamines,36–42 chitosan,43–49 enzymes,50–55 peptides, and
peptide mimetics.56–65 These agents have been immobilized
on a host of surfaces, including metals, plastics, and natural
and man-made fabrics.
The scope of this review includes literature wherein the
authors demonstrate immobilization and use some methods
to demonstrate efficacy with immobilization. In that context,
the modes of action, method of efficacy measurement,
immobilization strategies, and chemistry of the antimicrobial
agents are all discussed, with an emphasis on understanding
and interpreting the antimicrobial performance.
In many real world applications, the immobilization state
of the agent is irrelevant, and only the efficacy is of interest.
However, if there is a need to demonstrate that the antimi-
crobial agent (AMA) is efficacious and immobilized, for reg-
ulatory or mechanistic reasons, then this paper should help
to clarify what others have done, as well as pointing the way
for future researchers to direct their efforts.
II. ANTIMICROBIAL MODE OFACTION
When considering the immobilization of an antimicrobial
agent, it is valuable to consider the likely antimicrobial
mode of action and how this mode of action will be impacted
by the immobilization. Factors such as the chemical composi-
tion and dimensions of the extra-cytoplasmic bacterial compo-
nents (membranes, peptidoglycan wall, capsule, fimbriae, and
flagella, if present) are expected to be relevant to the perform-
ance of surface tethered AMAs. For example, the immobiliza-
tion of an antibiotic like a tetracycline via a short tether (5 nm)
would seem to be a pointless venture, given that the mode of
action for tetracycline involves disruption of the binding
between 16 S ribosomal ribonucleic acid and transfer ribonu-
cleic acid.66 This immobilization of tetracycline would severely
restrict its access from the cell interior, thereby dramatically
reducing, if not eliminating, the AMA’s efficacy. AMAs with
modes of action that require only external contact, or even
charge induced membrane interactions, might be more appro-
priate choices for immobilized antimicrobial agents.
Many papers have discussed theoretical modes of action
for immobilized antimicrobial agents (iAMAs).2,67–74
Among the common mechanisms are (1) physical lysing of
the membranes, (2) charge induced disruption of the mem-
brane potential, (3) solubilization of the membrane phospho-
lipids creating physical holes, and (4), in the case of
peptides, a wide range of interesting supramolecular assem-
blies. However, often very little is known about the detailed
mode of action for a specific agent, especially for newly
developed molecules, and in many cases the mode of action
might be completely unknown. This lack of information
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should not inhibit the research, but perhaps this could guide
the choice of immobilization and measurement strategies.
A. Efficacy testing
When it comes to immobilized antimicrobial agents, the
choice of an appropriate antimicrobial efficacy test method
and interpretation of the results can often require a sophisti-
cated understanding of disparate scientific disciplines. For
example, it is valuable to understand the potential mode of
action, the mass transport of the agent from the sample, the
potential interferents in the test medium, and the manner in
which the bacteria will sample the available surfaces.
Mass transport is one of the topics that are rarely dis-
cussed, as standard methods are applied to immobilized
AMAs, specifically, planar diffusion with and without con-
vection.75 When the immobilization state of the AMA is
unclear, or when a microbiological test method is to be used
to discern the immobilization state, then it is useful to con-
sider how mass transport of the AMA from the sample will
manifest in the test method. For example, does it develop a
concentration gradient at the surface, perhaps in a stagnant
layer? What is the dimension of that layer, and how does the
concentration of the agent in that layer compare to the bulk
concentration outside the stagnant layer? If cells enter this
region, and perhaps adhere to the surface, then they will
likely accrue in concentrations much greater than in the
bulk, but how much greater depends upon numerous varia-
bles. Understanding the mass transport of bacteria to the
surfaces and of the AMA from the surfaces can provide
much needed insight when attempting to discriminate
between bound and leachable agents.
Interpreting immobilized AMA data appropriately can be
a challenge when trying to assign efficacy strictly to nonelut-
ing agents. It is commonplace to modify standard methods
as the sample geometry or lab expertise dictates. This review
describes the most commonly used efficacy test methods,
highlighting the special needs that immobilized agents pose
for efficacy testing and commenting on the assumptions and
appropriateness of the methods for immobilized agents.
Table I provides an overview of how various immobilized
AMAs have been tested in the literature.
B. Zone of inhibition
Zone of inhibition (ZOI) methods involve placing an
AMA loaded substrate in contact with a growth media
loaded with bacteria. As the AMA elutes from the substrate
into the media, a zone can be observed in which the concen-
tration exceeds the minimum inhibitory concentration (MIC)
or critical concentration for that AMA. The size of the zone
is related to the diffusion constant for the AMA in the media
as well as to the total amount of agent that is available to
diffuse.76–78 Drugeon and coauthors describe in some depth
the physical basis of the ZOI method, and they focus on the
functional dependence of the zone size on key parameters
such as the agent mobility and quantity. This touches on a
key point that is relevant to many immobilized AMA stud-
ies: the quantity of AMA present on the surface is severely
limited, unlike with a swath of fabric or filter paper that is
soaked with an antibiotic. In the case of nonporous relatively
low surface area substrates modified with a densely packed
monolayer of AMA, the quantity of AMA that can elute
from the part is vanishingly small. This small number of
available molecules can readily limit the size of the zone to
microscopic distances. A brief calculation of the expected
zone is recommended for anyone using this method to con-
clude that the agent is immobilized. It might be that even if
all of the AMA molecules eluted from the surface, the vol-
ume corresponding to the critical concentration would corre-
spond to an undetectably small zone. Figure 1 shows an
example in which ZOI has been used with a polymer mono-
layer on a silicon substrate. The lack of a zone for the
polymer-silicon sample and the presence of a zone for a po-
rous scaffold soaked in the AMA were used to support a lack
of leaching from the 1.2 cm square silicon substrate. Using
simplistic calculations with some optimistic assumptions, we
can see that if all of the agent—say, 3 1011 molecules,
assuming a high 1 molecule/nm2 coverage over the geomet-
ric area of the silicon—eluted from the part and penetrated
uniformly into the surrounding volume, and if the minimum
concentration needed in order to establish a zone in which
growth was inhibited was 0.1 mM, then the zone would be
on the order of 20 lm. These numbers are overly optimistic,
as 0.1 mM corresponds to an aggressive AMA and the calcu-
lation assumes a uniform concentration across the 20 lm,
whereas the true distribution will be a gradient with most of
the agent closer to the surface. This is not to say that the
polymers in Madkour’s work are eluting, but that the ZOI
method is insufficient to prove the lack of elution.
Furthermore, it is important to compare similar environ-
ments. The growth media used for ZOI might be inappropri-
ate when the enumeration testing is performed in a much
TABLE I. Immobilization and test methods for various iAMAs.
Zone of
inhibition Immersion
Direct
inoculation
Surface
growth Luminescence Other
Small quaternary ammonium compounds 11,12,14,17 11–13,15,17 12,14,15 17 16 11–13,15,16
Quaternary ammonium polymers 18,20,21,28,31 19,24,26–31,33–35 20,21,30,31,33,35 24,26,29,30 19,30,33,34
Polyamines (1 to 3) 37,40 37,39 40 39,40 40 37,40
Chitosan derivatives 48 45
Enzymes 51 50–53 55 52,53
Peptides and mimetics 56,59,60,65 56,57,60,65 58,59
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cleaner saline suspension that has less nutrient and which
might contain fewer potential interferents. The interferences
will generate a higher MIC and will reduce the dimensions
of the zone by an amount that depends upon the extent of the
interference. This might be especially relevant for AMAs
that exploit charge-based interactions, as the nutrient rich
media common to ZOI experiments contain proteins and
polysaccharides that might contain ionized groups.
These two factors might lead to a spurious conclusion
that the material is not leaching from the part. The ZOI tests
are completely appropriate for porous pads loaded with anti-
biotics; however, much consideration should be given to the
above-mentioned points before equating the absence of a
zone to the immobilization of the agent.
C. Immersive inoculation
Many methods involve the immersion of the active sam-
ple into a media or saline solution that contains the inocu-
lum. The American Society for Testing and Materials
(ASTM) has developed a standard method for the antimicro-
bial efficacy assessment of immobilized antimicrobials,
ASTM E2149.79 This is one of the most widely used meth-
ods to test for the efficacy of immobilized samples. The
method measures the colony forming units (CFU) that derive
from an inoculum solution that was in contact with the sam-
ple. There can be confounding factors that affect the number
of CFU measured from the solution; for example, agent
could elute and kill cells that approach the surface of the
sample, or viable cells could be preferentially removed from
the solution via adhesion to the sample. Typically, a control
sample is used for comparison to the active sample.
Although the control and active samples are often made of
the same substrate material (same size, surface area, rough-
ness, etc.), unfortunately, due to the nature of chemical mod-
ification, the samples will likely have very different
chemistries. Often the active surface is positively charged,
whereas the control is not. This simple difference could have
an impact on the cell-surface adhesion. In immersion meth-
ods like ASTM E2149, the removal of live cells from the so-
lution via irreversible adhesion to the sample will produce
the same effect as killing the cells.
Some researchers have immersed the sample in an
inoculum-free solution and then inoculated that solution in
the absence of the sample.23 The intent is to test the efficacy
of any leached compounds, and a lack of efficacy is used to
rule out leaching as a factor for kill. Mass transport of the
agent from a surface is key in interpreting these results,75
and although the theory is conceptually rather simple and
well known, a predictive understanding can be very compli-
cated in a real-world system. Nonetheless, it can be instruc-
tive to consider the various possible outcomes. Firstly, if the
AMA is truly immobilized, the solution will be noneffica-
cious. Furthermore, if the AMA molecules rapidly elute
from a part to which the molecules are not strongly bound
and where there is limited porosity, then the concentration in
the bulk will rapidly approach a limiting value that will also
approach the surface concentration. If the bulk concentration
is adequate to kill, then it will be detected as efficacious, and
the conclusion will be elution. If the bulk concentration is
inadequate to kill (perhaps due to dilution of a limited supply
of AMA), then the conclusion will be that the agent does not
elute, when in fact it does but was diluted below the critical
concentration in that volume.
FIG. 1. (Color) Zone of inhibition assay for the antimicrobial surfaces: (a) untreated silicon wafer and (b) porous scaffold loaded with poly(butylmethacry-
late)-co-poly(Boc-aminoethyl methacrylate) highlighting the typical “zone of inhibition” observed in ZOI experiments. (c) Modified silicon wafer surfaces
containing 70 nm of poly(butylmethacrylate)-co-poly(Boc-aminoethyl methacrylate) shows no zone of inhibition. (Reprinted with permission from A.
Madkour, J. Dabkowski, K. Nusslein, and G. Tew, Langmuir 25, 1060 (2009). Copyright 2009, American Chemical Society.)
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An interesting outcome of this last condition can occur
when the elution rate is comparable to or less than the rate at
which the cells sample the surface. In that case, the plank-
tonic cells approach a surface that is still eluting agent, and
as they do so, they experience concentrations in excess of
the bulk concentration; as a result, those cells might die even
though the bulk solution remains far below the critical value
(even at the end of the experiment). In this case, we would
expect that the cells at the surface would be killed by eluting
agent, but that the solution inoculated without the sample
would not kill, perhaps leading to the incorrect conclusion
that the activity was due to immobilized agents. The exact
mechanism will depend upon several dynamic processes,
and will likely depend upon the bacterial species and its mo-
bility. This does not contradict previous experiments, but it
suggests that a comprehensive understanding of the mecha-
nism might benefit from a more critical tool than this test
method when attempting to discriminate between the immo-
bilized and leachable kill.
In a paper by Murata and coworkers, the authors chal-
lenged their samples with increasing inoculum and observed
an interesting limit to the efficacy of their surfaces
(1 108 E. coli/cm2). This value is approximately equal to
the closest packed surface coverage of these bacteria on a
surface. Testing to failure like this can be very informative,
and where appropriate, it is recommended in order to pro-
vide further mechanistic insight into the test method and
mode of action.
D. Direct inoculation
Several methods, such as the Japanese Industry Standard
(JIS Z-2801) method, place a small droplet of inoculum
directly in contact with the active surface. Although JIS
Z-2801 is not explicitly designed for use with immobilized
agents,80 it has nonetheless become common practice to
apply it to systems with purportedly immobilized agents.
This method involves placing a small droplet of inoculum
directly on the surface of the sample and then placing a cov-
erslip or film on top of the droplet, allowing capillary forces
to draw the surfaces together, thereby spreading the droplet
across the surface. Following the requisite inoculation time,
the entire assembly (both surfaces and the captive liquid) is
agitated, and released cells are typically enumerated as CFU.
This coverslip, which is not usually antimicrobial, can
adhere cells from the inoculum. It is not uncommon to see
JIS results for ostensibly immobilized agents with log reduc-
tion values on the order of 3 or more. Bacterial adhesion to
the coverslip will likely depend upon the bacterial strain and
the coverslip material; however, if even 10% of the inocu-
lum adheres to the coverslip, and if 10% of those cells are
recovered for enumeration, then the log reduction value
(LRV) is expected to be limited to less than 2. Therefore,
high LRVs for direct inoculation methods are seemingly in
contradiction to the immobilized nature of the agent. It
should be noted that the sample-coverslip separation is on
the order of 5 to 25 microns, and that diffusion across this
distance would be difficult to observe with ZOI, though ZOI
is sometimes used in conjunction with direct methods to
demonstrate efficacy and immobilization.
Some researchers have avoided this problem by excluding
the coverslip, thereby providing the cells with only one solid
surface, the sample surface. Our lab modified this direct
inoculation method with live-dead staining, and for the strain
we examined we were able to discriminate between kill at
the active surface and kill at the coverslip. In summary, extra
attention should be paid to these kinds of enumeration based
direct inoculation methods. This is especially true if the test
generates high LRVs, as this might be a good indication that
there was elution.
E. Surface growth methods
A number of innovative and effective methods involve
aerosol inoculation methods to apply a thin film of pathogens
across the surface. The bacteria are sometimes dried in place
and sometimes kept humidified. Following a specified inocu-
lation time, the activated surfaces and controls are then used
for growth based amplification via either direct contact with
a slab of agar or recovery for traditional enumeration. Figure 2
shows an example of this test method, in which both glass
slides were inoculated with an aerosol of bacteria. Clearly,
the untreated control grew more colonies than did the sample
treated with the antimicrobial agent. These test methods are
excellent for emulating ambient contamination of surfaces
and the corresponding antimicrobial efficacy of the surface;
however, regarding discrimination between immobilized and
elutable agents, there are a few points to consider.
These methods place the bacteria in very close contact
with the AMA coated substrate. Even when the bacteria
remain partially humidified, the volume of fluid in contact
with the AMA coated substrate is extremely small. Further-
more, even if all of the fluid between the bacteria and the
surface is removed, the bacterial surface is still in direct con-
tact with the surface, and diffusion of trace nonimmobilized
AMAs can still occur. In this geometry, the impact of eluted
agents will be greatly amplified as compared even with the
direct inoculation methods described above. By way of a
very coarse example, suppose that a 1 cm2 sample is inocu-
lated, and suppose that the same sample elutes enough free
AMA into a 10 ml solution to generate 1/1000 of the mini-
mum bactericidal concentration (MBC). Limited by the con-
centration at the source and allowing sufficient time for
equilibration, the concentration produced by the same
amount of material released into the constrained volume of a
thin film would be higher. In the case of direct inoculation
methods, a 10 lm thick film would result in a concentration
of 10 MBC. For aerosol based methods, the fluid layer
between the cells and the substrate is much thinner (say,
100 nm), and the relative concentration can approach 1000
MBC. Of course, 100 nm is probably thicker than expected if
the cell is in direct contact with the surface, and so higher
concentrations are plausible, as the concentration is limited
by the amount of free agent and the solubility of the agent in
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that fluid layer. This back of the envelope calculation simply
highlights the potential amplification by trace elutables of
the activity of the AMA modified surfaces. To the extent
that the mobility of the AMA is of interest, a more detailed
calculation or test would be needed in order to assess the
impact that these potential elutables would have on a real
system.
F. Viable but nonculturable
The above-described methods use the growth of colonies
to amplify the number of bacteria for quantitation and detec-
tion. Any growth based method will have a limitation when
it comes to viable but nonculturable (VBNC) microbes.80–83
The efficacy of the agent will be convoluted with the meth-
od’s ability to amplify the microbe by growth, and if the
microbe has been put into a VBNC state and resists growth
in the medium, then it will appear to have been killed by the
agent even though it actually remains viable, awaiting an
appropriate trigger or medium to reactivate. This is not a
problem specific to immobilized agents, but it bears consid-
eration in the selection of a test method for any antimicrobial
efficacy testing. This is a relatively recent field of research,
and as such it contains many new areas to explore. As it per-
tains to this review, the assessment of an immobilized
AMA’s ability to kill VBNCs will be strengthened by the de-
velopment of alternative methods tuned to the requirements
for those VBNCs. This will likely require a detailed under-
standing of particular species, strains, or even phenotypic prop-
erties. For example, the behavior of metabolic or membrane
permeable stains is expected to be affected by the specifics
of the VBNC state.
G. Luminescent signaling
Although growth based enumeration is familiar to micro-
biologists and produces quantitative data with a large
dynamic range, that level of quantitation is not necessarily
needed in order to assess the general efficacy of an AMA.
There are a number of semiquantitative methods that exploit
luminescence in order to detect the viability of microbes.
The most common of these methods use live-dead stain kits,
with which the stains probe various properties of the microbe
such as its membrane permeablity, metabolic activity,
etc.84,85
These kinds of fluorescent stains can be used with confo-
cal or epi-fluorescent microscopy, and recently these have
been exploited for enumeration based methods when com-
bined with flow cytometry.86,87 Our group has devised a con-
ceptually simple live-dead staining technique that can
determine whether the antimicrobial agent kills cells at the
surface or at a distance.88 The method uses a direct inocula-
tion method with spacers to separate an iAMA surface from
a control coverslip surface. The method generates three pop-
ulations of bacteria that can be compared: (1) those at the
control surface, (2) those at the test iAMA surface, and (3)
those freely floating in the solution. A comparison of the
bacterial fluorescence in the three populations can provide
insight as to whether the agent acts only at the substrate or is
able to affect the control bacteria. The process could be
FIG. 2. Photographs of a commercial NH2 glass slide (left) and a hexyl-PVP-modified slide (right) onto which aqueous suspensions (10
6 cells per ml of
distilled water) of S. aureus cells were sprayed. The slides were air dried for 2 min and incubated under 0.7% agar in a bacterial growth medium at 37 C
overnight. (Reprinted with permission from J. C. Tiller, C. J. Liao, K. Lewis, and A. M. Klibanov, Proc. Natl. Acad. Sci. U.S.A. 98, 5981 (2001). Copyright
2001, National Academy of Sciences.)
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extended to include alternate fluorophores, thereby probing
the metabolic activity or other properties of the microbes.
Live-dead staining has many potential limitations. For
instance, it has a limited dynamic range (usually from 5% to
95%, compared to enumeration methods that can vary over
several orders of magnitude). The live-dead staining can
depend upon the bacterial species, the strain, or the medium.
In the case of immobilized surfaces, the stains can some-
times interact with the substrate, producing high fluorescent
backgrounds.
As with the methods mentioned above, bacterial adhesion
to the surfaces is important when interpreting results for sur-
face tethered AMAs. The iAMA and control surfaces are
chemically different, and the relative adhesion of live and
dead cells to these two surfaces is typically unknown. Rins-
ing of the surface prior to imaging could potentially bias the
results by preferentially removing live or dead cells from ei-
ther of the two surfaces. In some cases when bacterial adhe-
sion is the goal, some researchers have exploited this by
combining rinsing with fluorescent imaging in order to probe
the extent of bacterial adhesion in antifouling experiments.
Some methods take advantage of bioluminescence gener-
ated within the cell to measure the metabolic activity of the
cell.60,89 These use genetically engineered lux-reporter
strains, and the luminescence is usually a measure of the res-
piration. Lux-reporters require some effort in order to create
each new bacterial strain, and therefore they are used for
only a limited number of species. Furthermore, the lux-
reporter cells are now different from the original strains,
because some of the lux-reporter cellular energy is diverted
in order to maintain the luminescence.
III. IMMOBILIZATION STRATEGIES
When the agent is identified as potentially attractive as an
immobilized AMA, the next step is to formulate a strategy to
immobilize the agent to a surface. Figure 3 illustrates a few
of the different strategies for the immobilization of AMA to
substrates: (1) “graft-to” strategies involve the covalent cou-
pling of the intact AMA to a surface via covalent linker
chemistries; (2) “physical adsorption” methods involve
physisorption of the AMA through noncovalent but strong
or multidentate interactions at the surface; (3) “surface
initiated” strategies involve the synthesis of the AMA from
initiators covalently immobilized to the surface; and (4) “as-
formed” methods involve creating a substrate that contains
the AMA when the substrate is formed.
A. Graft-to
Many of the iAMAs are formed by means of graft-to
strategies and begin with the synthesis of a potentially sur-
face reactive AMA. Frequently, the surface requires an acti-
vation process that generates amine, carboxylic acid,
aldehyde, or thiol functionalities. When activated, the sub-
strate is ready for additional reaction with heterobifunctional
linking chemistries that contain reactive groups such as succi-
nimide, carbodiimide, maleimide, or aldehyde.90 Sometimes
these linkers contain spacers such as polyethyleneglycol,
which serve to enhance the degrees of freedom for the
AMA, thereby enabling more modes of action and increasing
the efficacy. Alternatively, the AMA could have been modi-
fied to exploit click-chemistry for rapid clean immobiliza-
tion.91 Often, as in the case of polyethyleneimine, the
immobilization of the AMA is followed by further surface-
based reactions such as quaternization in order to produce
the final immobilized AMA.
B. Physical adsorption
The methods mentioned above involve the formation of a
chemical bond to the AMA. However, a single covalent
bond can be weaker than numerous noncovalent bonds. This
is the strength of many self-assembled structures such as the
deoxyribose nucleic acid double helix. This physical adsorp-
tion can take the form of hydrogen bonding, ionic bonding,
or even steric interactions caused by entanglement during
the solvent swelling of polymer films. One of the best exam-
ples of robust physically adsorbed films is the layer-by-layer
(LbL) film that uses multidentate polymer interactions to
bind the polymers to the surface.92 These are often combined
with eluting strategies, but in some cases quaternary ammo-
nium or another AMA is used as the outer layer of the LbL
system.93 Other physical absorption methods involve
exploiting the charge pairing or strong ionic bonding in order
to hold a smaller AMA to a substrate with an opposite
charge. When the physical interaction involves ionizable
groups, the pH of the environment is of key importance to
the stability of the film and the robust nature of the iAMA.
FIG. 3. (Color online) Various methods for immobilization: (a) graft-to or
physical adsorption, (b) surface-initiated synthesis, and (c) as-formed.
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C. Surface initiated or graft-from
In the surface initiated or graft-from strategy, the AMA is
essentially synthesized from surface bound initiators. Well-
defined polymeric structures have been created through
“living” or controlled polymerization techniques,94 such as
reversible addition fragmentation chain transfer polymeriza-
tion,95,96 nitroxide mediated polymerization,97 and metal
catalyzed living radical polymerizations such as atom trans-
fer radical polymerization (ATRP).98 In a similar but sub-
stantially more controlled manner, researchers can use solid
phase synthesis methods to graft specific sequences of
peptides and peptoids directly from a substrate. Cellulose-
amino-hydroxypropyl ether has been used to synthesize anti-
microbial peptides (AMPs) directly on cellulose substrates.
In a combination of surface-initiated and graft-to meth-
ods, researchers have used “dry” chemistries such as plasma
and chemical vapor deposition (CVD) to modify substrates
with complex polymer films.38 CVD was used to deposit a
polymer film from dimethylaminomethylstyrene and a ditert
amylperoxide initiator. The formed films were not structur-
ally characterized, but the researchers recorded rapid kill
with ASTM E2149 and observed no zone of inhibition
around the high surface area fabric.
D. As-formed
The as-formed strategy involves the inclusion of the
AMA within the polymer used to create the device substrate.
By mixing before forming, one is able to immobilize the
AMA via the nature of the substrate formation process. Ei-
ther crosslinking or entanglement with the substrate poly-
mers results in the AMA’s being immobilized. Nagel and
coworkers have demonstrated that surface reactive injection
molding can generate permanently modified parts, in their
case polycarbonate with polyethyleneimine (PEI) presented
at the surface.99 Namba et al. included an AMA within the
ingredients for methacrylic polymerization, thereby encapsu-
lating the AMA as an integral component of the matrix.12
IV. IMMOBILIZED AGENTS
A wide range of molecules have been immobilized and
tested as antimicrobial agents, including amine containing
polymers, quaternary ammonium polymers, guanides,
enzymes, chitosan, peptides, peptoids, and other peptide
mimetics. The following sections highlight key publications
that have explored each of these different classes of agents.
A. Quaternary ammonium silanes and other small
molecules
Historically, the first immobilized antimicrobial agent
was the silane (3-trimethoxysilyl) propyldimethyloctadecyl
ammonium chloride10 (Si-QAC). This molecule, and its
related silane analogues, can form direct covalent linkages to
silicates, oxides, and many plasma activated polymers. Fur-
thermore, as with any tri-alkoxy silane, this molecule can
autopolymerize to form long branched polymer chains with
an (-Si-O-) backbone. The quaternary ammonium side
chains on this siloxane polymer form a motif similar to that
of the quaternary ammonium polymers that followed.
In a seminal paper by Isqueth, Abbott, and Walters,11 a
quaternary ammonium silane was immobilized and found to
retain its antimicrobial efficacy. The silane was bound to a
wide range of different substrates, including siliceous surfa-
ces, man-made fibers, natural fibers, metals, and assorted
industrial materials. These modified surfaces were tested
against bacteria (both Gram positive and Gram negative),
yeast, algae, and fungi. A modified version of ASTM 2149E
and an aerosol method were used for antimicrobial efficacy,
and elution of the agent was tested using radiolabeled
agents.
In a paper by Gottenbos et al.,16 this silane was reacted
with argon plasma activated silicone rubber, and a suite of
surface analytical tools supported the presence of the silane
on the surface. Interestingly, this study used a flow cell com-
bined with rinsing and staining with a live-dead kit.
Although the live-dead stain does not provide a large
dynamic range, it clearly demonstrated that the modified
surfaces supported more dead bacteria than did the unmodi-
fied controls. Whether this was due to a causal based surface
killing of the bacteria or an enhanced adhesion of membrane
compromised cells to the surface is unclear. Nonetheless, the
effect was observed even after the surfaces were exposed to
human plasma, as shown in Fig. 4. The authors also per-
formed a series of in vivo experiments. In one case, the sam-
ples were inoculated and rinsed ex vivo prior to being
implanted, and in another study samples were implanted and
inoculated in vivo. The authors observed that the samples
inoculated ex vivo were efficacious, whereas those inocu-
lated in vivo were not.
Still others have used this Si-QAC as a nonleaching treat-
ment for cellulose.14 Although FTIR and XPS demonstrated
that the molecule was associated with the substrate, the data
do not definitively prove that the molecules are necessarily
bound to the substrate. The authors used ZOI along with JIS-
Z2801 to demonstrate nonleachability.
In addition to these quaternary ammonium silanes, other
small molecules such as aminoglycoside antibiotics have
been immobilized. Osinska-Jaroszuk et al. reacted gentimi-
cin and amikacin with vascular stents via aldehyde coupling
chemistry.12 Although some of the molecules might have
been covalently reacted with the stents, the parts clearly
developed a substantial zone with ZOI, seemingly in direct
contradiction to the covalent nature of the agent. Nonethe-
less, the stents are efficacious and can function as intended,
though most likely via elution of weakly associated antibi-
otic molecules.
In a similar study, Namba and coworkers immobilized
cetylpyridinium chloride (CPC) via physical incorporation
within a polymethacrylate matrix using an as-formed
method.13 They demonstrated that these surfaces function to
inhibit biofilm formation, and they used ZOI to support the
assessment that the CPC was not eluting. Based on the dis-
cussions above and the lack of any clear force holding the
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CPC to the substrate, it seems plausible that the agent is elut-
ing to kill bacteria at or near the surface.
B. Quaternary ammonium polymers
The most thoroughly studied class of AMAs is the quater-
nary ammonium polymers,18–21 and these have included
polymer backbones such as PEI, polyvinylpyridinium
(PVP), chitosan, and assorted acrylates. These polymers
have been immobilized using virtually every method listed
above, and they are often modified by post-immobilization
reactions. The Klibanov group has pioneered much of the
graft-to work with PVP and PEI. Immobilization of the
amine containing polymer usually involves control over
the surface density and is usually followed by on surface
quaternization with different sidechains and counter-
ions.17,22,30,31 Other groups, most notably Russell and Maty-
jaszewski, have led the surface initiated efforts using
controlled ATRP reactions.24,26–29 The works from the Kli-
banov and Russell groups have systematically probed the
antimicrobial impact of key properties such as the surface charge
density, polymer chain length, polymer chain density, counter
ion identity, and quaternary ammonium sidechain length.
1. Aliphatic quaternary ammonium polymers
Lin and coworkers performed a comprehensive study of
immobilized PEI using graft-to methods that examined the
length of the sidechain and the charge of functional groups.35
The immobilization was followed by alkylation, acylation,
or carboxyalkylation to generate cationic (quaternary ammo-
nium), neutral (amide), and zwitter-ionic (quaternary ammo-
nium carboxylic acid) functional groups, respectively.
Alkylation was performed with a range of chainlengths
(ethyl, Butyl, hexyl, dodecyl, and octadecyl) followed by
subsequent methylation to quaternize the amine. These reac-
tions were performed on glass slides as well as iron oxide
nanoparticles. The efficacy testing for the glass slides
involved the aerosol inoculation of slides, followed by dry-
ing. After a time, the slides were covered with agar and incu-
bated, and the subsequently grown colonies were counted.
The bactericidal efficiency was determined by taking the ra-
tio of the colonies formed on the sample to the number
formed on the aminosilane control. Their results showed that
a positive charge was necessary, because the neutral and
zwitter-ionic surfaces were not efficacious. The authors also
concluded that when it is terminally methylated, the alkyl-
ating group’s chainlength should be greater than that of n-
Butyl for a high efficacy. They found similar results for both
Gram positive (S. aureus and S. epidermidis) and Gram neg-
ative (E. coli and P. aeruginosa) bacteria.
Haldar and coworkers also examined the charge and the
sidechain length, but with an immobilization scheme that is
like a combination of an as-formed and a physical adsorption
approach. They painted hydrophobic derivatives of branched
and linear PEI onto glass slides.23 The derivatives covered a
range of molecular weights, were formed prior to painting, and
were modified to have net cationic (N,N-dodecylmethyl-PEI,
N,N-docosylmethyl-PEI), zwitter-ionic (N-(15-carboxypen-
tadecyl)-PEI HCl salt), anionic (N-(11-carboxyundecanoyl)-
PEI), and neutral (N-undecanoyl-PEI) charges. The painting
process did not immobilize the molecules covalently; instead
the authors exploited the inherently poor solubility of these
polymers as a barrier to dissolution in the inoculum. The
study demonstrated the efficacy of the cationic polymers
against aerosol based microbes (E. coli, S. aureus, and influ-
enza virus) with a greater than 4 log reduction in CFU or pla-
que forming units within minutes of exposure. In an effort
to demonstrate that leaching was not impactful, the authors
performed two tests: (1) an extraction from a painted sam-
ple, and (2) an extraction from 200 mg/ml of the pure
agents. In each case the bulk “extraction” buffer solution
was then inoculated with microbes and tested for efficacy.
As with many elution tests, this probes the amount of mate-
rial that can dissolve into the aqueous phase and asks
whether this bulk solution concentration is adequate to
impact the efficacy test. The second method is much
FIG. 4. Numbers of adhering viable (black bars) and nonviable (white bars)
bacteria on silicone rubber (SR) and quaternary ammonium silanized sili-
cone rubber (QAS) with and without adsorbed plasma proteins (SRþp and
QASþp). Error bars represent the SD over six images collected in two
experiments, with separately cultured bacteria and differently prepared
coatings. (Reprinted with permission from B. Gottenbos, H. C. van der Mei,
F. Klatter, P. Nieuwenhuis, and H. J. Busscher, Biomaterials 23, 1417
(2002). Copyright 2002, Elsevier.)
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stronger, as it involves what is essentially a saturated solu-
tion of the agent, whereas the first method might still have
a locally high concentration at the surface due to the diffu-
sion gradient’s slowly increasing the bulk solution concen-
tration. However, both methods are expected to yield
concentrations that are much less than the apparent concen-
tration at the interface.
Compared with living polymerization methods, conven-
tional radical polymerization tends to offer poor control over
the molecular weight, polydispersity, and chain branching
structure.
In order to address the lack of control, Huang and co-
workers performed graft-to immobilization of block poly-
mers created by ATRP to contain surface grafting regions
and dimethyl amine regions.26 The surface density of the im-
mobilized quaternary ammonium (QA) groups was con-
trolled via the polymer solution concentration, immersion
time, and molecular architecture. Fluorescence and atomic
force microscopy (AFM) measurements were used to quan-
tify the density of chains on the surface, and the results were
correlated with the antimicrobial efficacy, as shown in Fig. 5.
Interestingly, when comparing graft-to and graft-from surfa-
ces with comparable densities of QA groups, the graft-to
surfaces were more efficacious. The authors hypothesize that
this is due to the observed heterogeneity in the graft-to films,
which results in local regions of higher relative QA densities.
By using micropatterning they were able to generate areas of
the substrate where the agent was immobilized directly next
to areas free of the AMA, as seen in Fig. 6. This enabled
their live-dead stain images to spatially differentiate between
kill over the immobilized agent and kill in neighboring,
unmodified areas (less than a few microns away). This pro-
vides a highly credible method for stating that the agent does
not kill by elution, and it is essentially a microscopic version
of the ZOI test, but instead of taking place under growth con-
ditions, it occurs under the more relevant test conditions.
The paper makes frequent connections between interesting
mechanistically relevant molecular properties of the film and
the efficacy—for example, the number of QA groups needed
to kill a bacterium, whic in this case is 1010 QA/bacterium.
In order to take the level of control further, quaternary
ammonium polymers (PQAs) have also been formed via sur-
face initiated living polymerization methods. In a paper by
Murata et al., glass surfaces coated with initiators were used
to polymerize dimethylaminoethylmethacrylate via ATRP.24
These polymers were then quaternized via reaction with
alkylhalides to form immobilized PQAs. By controlling the
surface density of the initiators and the reaction time for
the polymerzation, they were able to independently control
the polymer density and polymer length, respectively. By
using fluorescence to quantify the surface charge density, as
well as live-dead staining to determine the local efficacy, the
functional dependence of the efficacy on the surface charge
density was demonstrated. The authors concluded that the
key operational parameter in the efficacy was the surface
charge density, and not necessarily the polymer length. This
has mechanistic implications, which they explored and com-
pared to other examples in the literature. They determined
that a threshold charge density of 5 1015 charges/cm2 was
needed for efficacy against E. coli. They also noted that the
surface charge for an E. coli is in the range of 1014–1015
charges/cm2, depending on the growth stage of the cell.
Milovic and coworkers reported on the apparent lack of
resistance that the bacteria develop upon repeated exposure
to fresh surfaces of graft-to N-alkylated quaternary PEI.30 In
this insightful study, the samples of aminopropylsilane
modified glass slides were coupled to PEI that was subse-
quently N-hexyl and N-methyl quaternized. Based on the
live-dead staining data, both E. coli and S. aureus were
effectively killed within 1 h of exposure to the surface. Only
a small fraction of the aerosolized bacteria that contacted the
surface developed colonies via a surface growth amplifica-
tion method. By repeatedly sampling bacteria from the
FIG. 5. (Color) Biocidal activity of the surfaces vs the density of QA units
on surfaces (2.9 105 bacteria in control; surface area¼ 5 cm2). (Reprinted
with permission from J. Huang, R. R. Koepsel, H. Murata, W. Wu, S. B.
Lee, T. Kowalewski, A. J. Russell, and K. Matyjaszewski, Langmuir 24,
6785 (2008). Copyright 2008, American Chemical Society.)
FIG. 6. (Color) Fluorescence microscopy image of E. coli on a PQA-
patterned glass slide. The image is a result of the superposition of an image
with a green band-pass filter showing intact bacteria and an image taken
using a red band-pass filter showing bacteria with damaged cell membranes.
Bar size is 50lm. (Reprinted with permission from J. Huang, R. R. Koepsel,
H. Murata, W. Wu, S. B. Lee, T. Kowalewski, A. J. Russell, and K. Matyjas-
zewski, Langmuir 24, 6785 (2008). Copyright 2008, American Chemical
Society.)
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surviving colonies and re-challenging each new culture with
fresh surfaces, the authors demonstrated that the bacteria did
not develop resistance over the course of 11 exposures.
2. Aromatic quaternary ammonium polymers
In addition to the commonly observed aliphatic quater-
nary ammonium AMA, some researchers have been explor-
ing the impact that pyridinium based quaternary ammonium
ions have on antimicrobial efficacy.32 Tiller and coworkers
not only detail the dependence of the side-chain chainlength
with pyridinium polymers, but they also present a spray-
growth amplification method for qualitatively assessing the
efficacy.21 Figure 7 shows that these authors found that the
chainlength of the N-alkylated group impacted the efficacy
of the agent, with hexyl ammonium quats having the greatest
efficacy relative to the longer or shorter chainlengths. Sub-
strates were challenged by airborne and waterborne E. coli
experiments to test for antimicrobial activity. The airborne
assay was performed by spraying E. coli onto surfaces and
allowing it to dry. The substrates were placed in a sealed Pe-
tri dish with growth agar and incubated in order to allow the
viable bacteria to grow into colonies for counting. The
waterborne test was performed by immersing the substrate in
a suspension of microbes and then rinsing it before it was
sealed and incubated. Colony growth was tracked with scan-
ning electron microscopy and through colony counting in the
agar with optical microscopy.
A careful reading of the literature will show that the most
efficacious chainlength for the side chain is a point of con-
tention and varies from Butyl to hexyl (as above) to decyl
and dodecyl. Although the mode of action is still unclear, it
is the authors’ opinion that the charge density mechanism,
which has been postulated by several labs, is likely the domi-
nant factor. This mode has been hypothesized to be rooted in
ion exchange with membrane and cell wall components. It
seems plausible that the ion exchange will be affected by the
polarizability and local environment of the immobilized
AMA cations. In the case of the aromatic groups for which
no methylation is needed, the environment is markedly dif-
ferent from that of the aliphatic tetrahedral quaternary am-
monium group. With differences such as these, it is perhaps
not surprising that the optimum chainlength would be differ-
ent. The authors do not subscribe to the notion that the opti-
mum chainlength is related to the hydrophobic side chain
penetrating the membrane. The steric limitations of the poly-
mer and surface structure caused by immobilization com-
bined with the dimensions of the bacterial envelope seem to
be at odds with this kind of intercalation. Of course, if trace
amounts of the agent are free to elute from the surface, then
this kind of molecular intercalation (and corresponding
chainlength dependence) could certainly be more plausible.
Kugler et al.25 performed charge measurements on qua-
ternized PVP films and reported rapid kill in less than 10 min
with live-dead staining. They also performed some interest-
ing analyses of the film thickness and bacterial state. The
film thickness was measured using ellipsometry. They found
that the different cellular states (low or high cell division
conditions) required different surface charge densities for
E. coli and S. epidermidis of 1014 Nþ/cm2 in the low cell di-
vision state and 1013 and 1012 Nþ/cm2 in the high division
conditions, respectively. Given that they observed efficacy
for films with a thickness of 2 nm, they proposed that their
data support an ion exchange mechanism of efficacy that has
been previously discussed.21,100,101
Poly(vinylpyridine) AMAs have been synthesized from
the surfaces of cellulose, polyethyleneterephthalate, and
electrospun polyurethanes.33,34 In each of these experiments,
the authors initiated the polymerization of PVP from plasma
activated surface sites. These PVP modified surfaces were
then quaternized with hexylbromide. Yao et al. challenged
the electrospun membranes with S. aureus and E. coli via an
immersion method. The modified membranes showed a
higher propensity for cell death for the S. aureus than the E.
coli, with the former having a 5 log reduction in viable cell
count after 4 h and the latter having an LRV of only 3. SEM
images of the membranes showed the absence of intact cellu-
lar material on the treated samples; therefore, the reduction
was not due simply to selective adhesion to the sample.
3. Fluorinated quaternary ammonium compounds
The nature of the side-chains on the quaternary amine has
also been explored. The most notable success has involved
the use of perfluorinated side groups. Krishnan et al. quater-
nized pyridinium polymers with a perfluorinated side
chain,92 although this work was not a direct comparison of
fluorination because the fluorinated (F(CF2)8(CH2)6Br) and
nonfluorinated (H(CH2)6Br) molecules were of different
FIG. 7. Percentage of S. aureus colonies grown on the infected surfaces of
glass slides modified with PVP that was N-alkylated with different linear
alkyl bromides relative to the number of colonies grown on a commercial
NH2-glass slide (used as a standard). The bacterial cells were sprayed from
an aqueous suspension (106 cells per ml) onto the surfaces. All experiments
were performed at least in quadruplicate, and the error bars indicate
the standard deviations from the mean values obtained. (Reprinted with
permission from J. C. Tiller, C. J. Liao, K. Lewis, and A. M. Klibanov,
Proc. Natl. Acad. Sci. U.S.A. 98, 5981 (2001). Copyright 2001, National
Academy of Sciences.)
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lengths. The samples were glass slides that were coated with
styrene ethylene butylene styrene (SEBS). This polymer
surface was then sprayed with PVP and annealed. In
this way the PVP was physically adsorbed to the SEBS
film. The resulting surface was then quaternized with the
aforementioned alkylbromides. As an aside, they also noted
that complete quaternization led to reduced efficacy, and that
better antimicrobial properties were observed with a lower
quaternization fraction.
C. Amine containing polymers
The quaternary ammonium compounds are known to be
antimicrobial, but some work has also examined the efficacy
of the less substituted tertiary, secondary, and primary
amines. Lichter and Rubner studied the efficacy of LbL films
composed of the primary amines polyallylamine hydrochlor-
ide (PAH) and polystyrene sulfonate (PSS).39 Spray and
immersion based methods were used to challenge the sur-
face, followed by growth based amplification methods to
quantify the viability. Their conclusion was that the efficacy
depended primarily upon the generation of a surface with a
sufficient positive charge density, a hypothesis further sup-
ported by work done by Russell’s group.26 In that work, they
affected the charge via the choice of the last layer (positive
for PAH or negative for PSS) and the pH of the final rinse
solution relative to the pKa of the PAH.
Martin et al. used plasma polymerization methods to po-
lymerize the tertiary amine dimethylaminomethylstyrene to
create polymer coated fabric surfaces.38 They characterized
the coating process via added mass and FTIR spectroscopy.
A correlation between the reaction time and the amount of
polymer added was established, and the FTIR was consistent
with the presence of tertiary amine. The efficacies of these
fabric swatches were tested via ASTM E2149, and the
authors observed that a critical added mass was needed in
order to attain substantial antimicrobial efficacy, a finding
that is consistent with previous work that observed a critical
charge density. A 6 to 7 log reduction in microbe activity
relative to unmodified controls was observed, and the
authors confirmed that their fabric swath generated no visi-
ble “zone” with a ZOI test. Finally, the extracted solution in
contact with the sample also generated no zone.
Madkour and coworkers created ATRP polymethacrylates
with Butyl and ethylamine groups.40 The film thicknesses
ranged from 3 to 70 nm. All gave rapid and complete kill,
and dilution of the surface initiators from 100% to 1% had
virtually no impact on the performance of the film. Further-
more, the films lost antimicrobial activity with repeated ex-
posure/rinsing cycles. The paper reported massive kill via
the aerosolized inoculation method as determined by live-
dead stain within 5 min of aerosolization. A modified JIS
style test avoided the use of a coverslip, but spray deposition
on the substrate enhanced any impact that potentially trace
elutable agents would have by effectively concentrating
them in a miniscule liquid between the cells and the sub-
strate. The evidence against elution was the ZOI test, based
on the fact that these polymers have been shown to be effica-
cious in solution.41
D. Guanidinium-based molecules and polymers
Guanides, biguanides, and their polymers have long been
recognized for their antimicrobial activity and low human
toxicity. Chlorhexidine (CHX), polyhexamethylenebiguanide,
polyhexamethyleneguanide (PHMG), various oligoguanides,
and other biguanides are known to be efficacious in solu-
tion.4,76 Furthermore, their mode of action has long been
linked to the disruption of the bacterial membranes. Asadi-
nezhad and coworkers reacted chlorhexidine with surface
initiated polyacrylic acid via ethyl(dimethylaminopropyl)
carbodiimide (EDC) coupling to the CHX secondary amine
groups and then used glutaraldehyde to crosslink neighbor-
ing CHX molecules. The reactions on the polyvinyl chlo-
ride (PVC) substrate were followed by FTIR, XPS,
SEM, and finally bacterial adhesion.102 The authors con-
cluded that medical grade PVC modified in this way was
more resiatant to the bacterial adhesion of S. aureus and
E. coli.
In a paper by Chen et al.,103 the authors reported combin-
ing electrospun cellulose acetate with chlorhexidine, polye-
thyleneglycol (PEG), and a triethanolamine titanium
complex (Tyzor
VR
TE) to generate composite polymer fiber
meshes. The fibers were cured and the CHX composition
was characterized via FTIR, Raman spectroscopy, and XPS.
ZOI tests were used to assess the lack of elution and provide
support for the immobilization of the CHX. The authors
offer some detailed calculations for the ZOI beyond the nor-
mal treatment, and they used ASTM E2149 to verify that the
agent modified parts were efficacious. They observed that
the chlorhexidine modified parts killed at a 2 to 3 log
reduction at the highest weight percents of 8% CHX.
Guan and coworkers104 reacted the primary amine end
groups of PHMG with glycidyl methacrylate to make a
unique polyguanidylmethacrylate monomer. They then
copolymerized this monomer from sulfite pulp (cellulose
fibers) using ceric ammonium nitrate as an initiator. This
modified cellulose was then characterized via energy disper-
sive x-ray, FTIR, charge density, AFM (topography and ad-
hesion), and gravimetry (grafting efficiency). The authors
measured the antimicrobial efficacy via a shake flask method
very similar to that described in ASTM E2149. The results
showed a substantial reduction (LRV> 4) of the bacterial
viability within a 48 h inoculation.
E. Chitosan
Like guanide compounds, chitosan has long been reported
as a naturally occurring antimicrobial polymer. Numerous
researchers have immobilized chitosan to fibrous substrates
such as wool, cotton, pulp, etc. These investigations have
typically combined immersion inoculation methods with
ZOI in order to demonstrate efficacy and support a lack of
elution; because neither method reveals much about the
immobilization of the molecules, the immobilized status of
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the molecules is suspect. In a study by Vartiainen and
coworkers, polypropylene films were plasma activated and
coupled to medium molecular weight chitosan.45 The cou-
pling involved plasma treatment with an NH3 or CO2 rich
atmosphere, with the intent of creating amine and carboxylic
acid groups on the polymer surface. Chitosan was coupled to
the substrate by using either glutaraldehyde or EDC coupling
chemistries, and the samples were characterized via FTIR,
SEM, and contact angles. The antimicrobial activity was
assessed by placing 0.1 ml of inoculum in direct contact with
the surface. The samples were inoculated for 24 h at 25 C
under humidified conditions. The cells were then diluted and
displaced from the sample by gentle shaking, and the viabil-
ity of the cells in the supernate was enumerated via standard
plating methods. The authors observed a 3 to 5 log reduction
in the viable bacteria, depending on the bacterium (E. coli or
B. subtilus). Carlson and coworkers49 coated PMMA sub-
strates with chitosan and observed that the surfaces were
antimicrobial. By exploiting live-dead staining and time-
lapse confocal fluorescence microscopy, they were able to
observe that as the cells approached and interacted with the
surface, the cell membranes became permeable to the fluo-
rescent dye.
F. Peptides
Bacteria, protozoa, fungi, plants, and animals produce a
host of antimicrobial peptides,105–107 many of which are
documented in an online antimicrobial peptide database.108
The database can be searched and sorted according to the
mode of action on record. By restricting immobilization can-
didates to those AMPs that are known for membrane disrup-
tion, the list is reduced to a manageable size, such as
magainin I, polymyxin B, defensins, apoprotinin, nisin, etc.
Hilpert and coworkers put together an excellent piece of
work that correlates the peptide structure (charge, hydropho-
bicity, and spatial structure) with the antimicrobial func-
tion,60 and through systematic variations around known
peptide sequences they identified a number of efficacious
agents. They characterized the peptide efficacy by both solu-
tion (MIC) methods and luminescence from lux-reporter
strains in wells with surfaces modified with the agent. Their
review demonstrated that many of the efficacious AMPs
were able to form some sort of amphipathic and cationic
structures.
Humblot and coworkers immobilized magainin I (MAG)
to a self-assembled monolayer of carboxylic acids on gold
by using standard EDC/N-hydroxysuccinimide coupling to
react with free amine groups on the MAG.56 The surfaces
were fully characterized via polarization modulation infrared
reflection absorption spectroscopy, XPS, and AFM. The gold
samples were inoculated by immersion and then rinsed. The
adhered bacteria were live-dead stained, and fewer than half
of the cells were stained alive. The authors concluded that
although the MAG was effective at killing the cells that
came into direct contact with the surface, the remnant dead
cells might offer support for further cell attachment and
growth that would be protected from the immobilized agent.
Glinel and coworkers grew a polymer film via ATRP
composed of hydroxyl-terminated PEG groups. This largely
antifouling surface was augmented by graft-to reactions of
C-terminal cysteine modified MAG with the hydroxyl
groups using p-maleimidophenyl isocyanate (a heterobifunc-
tional reagent used to couple hydroxyl groups to thiols). In
this way, the MAG was bound at a specific site and on the
end of PEG tethers hanging off of the brush of a polymetha-
crylate backbone. The authors were able to vary the surface
density of the peptide, and they found that even low immobi-
lization densities were efficacious. The samples were inocu-
lated via immersion in suspensions of two Gram-positive
bacteria (Listeria ivanovii and Bacillus cereus), lightly rinse-
d,and stained with a live-dead stain. The efficacy was
assessed via confocal laser scanning microscopy of the
stained cells. The images demonstrated that some of the fila-
mentous B. cereus and all of the L. ivanovii cells that
remained following rinsing were dead.
Polymyxin B (PMB) has been immobilized to adhere and
subsequently detect Salmonella typhimurium and E. coli.57
Tzoris and coworkers were able to immobilize PMB to a rad-
ical polymerized copolymer of ethylacrylate and hydroxye-
thylacrylate. The hydroxyl groups were reacted with the
amine groups on the PMB via standard coupling reactions
using tresyl chloride. The authors determined that the PMB
was not leaching via a novel ion selective FET method as
well as a fluorescent labeling experiment. This led them to
conclude that the elution in solution would be much less
than the MIC for PMB.58 They then determined the antimi-
crobial efficacy using an optical density measured growth
curve lag between inoculated media that was or was not
exposed to PMB immobilized glass. The bacteria in the
media exposed to PMB glass had a delayed growth curve.
From this, the authors concluded that the PMB was immobi-
lized and efficacious while immobilized. Elastomers such as
polydimethylsiloxane have also been modified with AMPs in
an effort to attain antibiofilm properties.59
When considering AMPs, it is instructive to consider the
mode of action. Although the modes of action of AMPs are
still relatively unknown, there is substantial literature
hypothesizing concerted multipeptide arrangements into
complex quaternary structures (barrels, staves, and carpets)
at the bacterial membrane. As a result, the antimicrobial per-
formance of AMPs might be even more sensitive to immobi-
lization than that of the simple polycationic systems
mentioned above.
Patch and Barron give an excellent review of non-natural
peptidomimetic oligomers.63 As mimics can be found for
virtually any peptide function, it is not surprising that some
mimics have been identified for antimicrobial functionality.
Statz and coworkers65 examined the impact that surface
bound peptide mimetics have on E. coli adhesion. In that
study, the authors immobilized three different peptoid
sequences to titania substrates: an antimicrobial peptoid,
an antihemolysis/antifouling peptoid, and a filler peptoid.
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Immobilization was confirmed with an assortment of surface
analytical tools, and the antimicrobial efficacy of the surfaces
was determined via fluorescence microscopy. The fluores-
cence data agreed with the solution phase MIC data for the
free peptoids. One of the key advantages of these artificial
peptoid motifs is their resistance to natural enzymes. This
area is still very new, and relatively few mimetics have been
immobilized and tested for antimicrobial efficacy.
G. Enzymes
A number of enzymes have evolved as antimicrobial
agents in natural settings, and several of these naturally
occurring enzymes have been used as bactericidal and anti-
biofilm agents. Chitinases have been mobilized against
fungi, and proteases have been applied against prions. Auto-
lysins are a group of enzymes generated by bacteria for regu-
lation of their own cell wall, and they are usually highly
specific to the originating bacteria. Common antimicrobial
enzymes include proteinase K, trypsin, subtilisin, protease
A, papain, umamizyme, dispersin B, neutrophil elastase,
phospholipase A2, and of course lysozyme. Lysozyme has
been immobilized to fabrics such as cotton51 and wool,50 as
well as to polymer substrates such as polymethylmethacry-
late, polyethylene, polypropylene, and polystyrene.52,53
Conte et al. reacted crosslinked polyvinylalcohol (PVA)
with lysozyme via gluteraldehyde, and the crosslinked solution
was cast onto PMMA substrates. The elution of the lysozyme
was tracked using high-performance liquid chromatography
and, following extensive rinsing, was determined to be negli-
gible. The antimicrobial efficacy of the immobilized enzyme
was monitored in the same way that the activity of the
enzyme would be determined, via a UV absorbance assay
for the lysis of Micrococcus lysodeikticus. The authors found
that the efficacy increased with the quantity of lysozyme im-
mobilized in their PVA matrix.
Efforts by Vartiainen and co-workers have led to the
immobilization of glucose-oxidase onto amine and carboxy
activated polypropylene using standard coupling chemistry
of glutaraldehyde and carbodiimide linkers, respectively.54,55
These films were found to be antimicrobial using a “drop
test” method109 similar to that in an uncovered JIS-Z2801. In
these cases, it should be noted that while the glucose oxidase
is immobilized, the efficacious agent (hydrogen peroxide) is
clearly free to diffuse from the surface, similar to chlorine
and N-halamines. Therefore, this is not actually an immobi-
lized enzymatic AMA. Enzymes have also been used to pro-
vide antifouling capabilities, as in the work by Asuri and
coworkers110 in which enzyme-nanotube composites were
created and the antifouling nature was verified.
V. CONCLUSIONS AND FUTURE DIRECTIONS
In summary, there is a significant need for increased
understanding of the modes of action of these surface bound
antimicrobial agents. The immobilization places restrictions
on the traditionally discussed modes of action. Some new
modes have been suggested based on the overwhelming cor-
relation with charge density, but these modes remain hypo-
thetical, with limited experimental evidence. To the extent
that the elution needs to be prevented and that the mode of
action should work while the agent is immobilized, addi-
tional testing methods should be employed. In the least, a
more critical use of the traditional testing methods should be
adopted. Zone of inhibition should be abandoned as a proof
of immobilization in all but extreme cases, and where used it
should be accompanied by some simple calculations that
demonstrate that its use is appropriate.
Of the various immobilization strategies, the surface-
initiated or graft-from approaches offer the most confidence
in the generation of samples that do not elute agent (truly im-
mobilized AMAs). The graft-to methods can be adequate, as
demonstrated in some cases described above, but in many
cases the surface associated AMAs are a mixture of physi-
cally and covalently adhered molecules, allowing for trace
elution of the physically adhered molecules over time. Fur-
thermore, some of the common linking chemistries
employed are labile (hydrolysis) and might degrade over
time or in some conditions of use. Physical adsorption is
generally a weaker immobilization method, but in some
cases, such as LbL films, the multidentate charge interac-
tions can lead to strong, essentially irreversible adhesion
comparable to or greater than that found in covalent systems.
However, depending upon the molecules, attention needs to
be given to the potential pH or ionic strength sensitivity of
the interactions, and those molecules not physically adsorbed
by these multiple interactions are at much greater risk of
elution. Perhaps the weakest systems, with respect to
immobilization, are the as-formed systems. These systems
often rely upon polymer intercalation or hydrophobicity to
keep the molecules associated with the sample. However,
time, pH, ionic strength, and the local environment of a cell
in contact with the surface can enable increased elution of
the molecule from the surface. However, the larger issue
with these methods comes from the nature of the agent.
Frequently, the agent is a high molecular weight polymer,
but these are not monodisperse, and shorter molecular
weight analogues will be more mobile and can elute while
the larger molecules remain at the interface. In each of
these cases, spectral data that associate a molecule with the
surface do not equate to immobilization. In addition to sur-
face association, some evidence for the molecules’ irrevers-
ible state should also be presented. The difficulty with the
analysis is that depending upon the efficacy test, trace
amounts of elution can have a biological impact, and so the
detection limits needed for the analysis can be quite
challenging.
When evaluating the appropriateness of various immobi-
lized agents for a specific application, there are several fac-
tors to consider, including the cost of materials and
processing, the efficacy, sensitivity to and methods of inacti-
vation, ease of use, the lifetime of the agent, and manufactur-
ability and stability to sterilization procedures. The surface-
initiated polymerization of highly positively charged surfa-
ces (quaternary ammonium polymers) has demonstrated
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efficacy and lack of elution at reasonable costs. Although
manufacturability requires more planning, control, and cost
than graft-to methods, groups such as the Matyjaszewski
group have demonstrated that even controlled processes
such as surface ATRP can be implemented in manufacturing
settings. As with all immobilized AMAs, surface contamina-
tion can lead to inactivation of these surfaces, and, in fact,
because these surfaces by their nature are highly positively
charged, they are expected to strongly interact with anionic
polymer cellular material. This inactivation simply limits
the application space to certain environmental conditions.
Graft-to coupling reactions of polyamines such as chitosan,
biguanides, and quaternary ammonium polymers are easy
to perform with standard chemistries and are readily ame-
nable to manufacturing at relatively low costs. These are
typically also highly charged and thus are subject to similar
contamination limitations. Peptides and enzymes need to
be coupled via graft-to, and whereas the cost for grafting is
low, the cost for the agents can sometimes be very high,
especially in the case of the peptides. In the case of biologi-
cally created enzymes, the source of the molecules can
sometimes create additional regulatory hurdles and costs.
In addition to the increased material costs, these might also
pose greater manufacturing difficulties associated with the
sensitivity of the molecules to processing solvents, sterili-
zation, or other manufacturing conditions. Further limita-
tions of these will result from their restricted mobility when
immobilized, as their modes of action might require access
to parts of the cell that are difficult for them to reach while
immobilized. Lastly, and in addition to typical contamina-
tion based inactivation, these agents will have a reduced
lifetime as a result of proteolytic degradation due to
enzymes originating from host, the pathogen, or the
environment.
Emerging directions for the agents and the agent proper-
ties include a focus on combining antifouling with antimi-
crobial properties. Alternate, promising directions include
responsive or smart materials capable of switching from
antifouling to antimicrobial when stimulated by the presence
of microbes. In a closely related direction, some researchers
have focused on microstructured surfaces used to minimize
biofilm formation. Future developments of this textured as-
pect might generate added functionality, assuming that the
data are truly representative. As new materials are added to
surfaces for biomedical devices, the cytotoxicity will be of
interest; however, given that the agents are immobilized, the
toxicity is expected to be less important than for the corre-
sponding biomedical devices with leaching antimicrobial
agents.
Future developments will likely witness the application of
additional test methods for immobilized AMA devices.
Emerging areas for method development include VBNC test
methods and measurement capabilities with larger dynamic
ranges that properly measure and identify the kill as immobi-
lized or eluted. Rapid microbiology methods have tradition-
ally been utilized for the diagnosis of infectious diseases
and, more recently, are being implemented to provide better
control over manufacturing processes, as well as the earlier
release of products. These methods typically use fluorescent
probes or molecular biology methods such as reverse tran-
scription polymerase chain reaction and mass spectroscopy
to probe genomic, proteomic, or phenotypic differences in
order to detect and identify viable organisms. These methods
have not found their way into the efficacy testing of immobi-
lized agents in the literature; however, they have strengths
with respect to VBNCs and complicated realistic colonies
made up of multiple species or strains. Perhaps as improved
methods become available, some previously examined sys-
tems could be reexamined, with added attention paid to their
mechanistic implications.
Depending upon the stringency of the immobilized crite-
ria, there might be many examples of immobilized agents or
very few. This pursuit is complicated by the testing method
appropriateness, bacterial species/strains, resistance, and
simple microbe surface interactions. This review highlights
the efforts to date with regard to the immobilization of anti-
microbial agents, and it is intended to cast some critical light
on the appropriateness of the efficacy testing as it pertains to
truly immobilized agents.
Nomenclature
AFM ¼ atomic force microscopy
AMA ¼ antimicrobial agent
AMP ¼ antimicrobial peptide
ASTM ¼ American Society for Testing and Materials
ATRP ¼ atom transfer radical polymerization
B. subtilus ¼ Bacillus subtilis
CFU ¼ colony forming units
CHX ¼ chlorhexidine
CPC ¼ cetylpyridinium chloride
CVD ¼ chemical vapor deposition
E. coli ¼ Escherichia coli
EDC ¼ ethyl(dimethylaminopropyl) carbodiimide
FET ¼ field effect transistor
FTIR ¼ Fourier transform infrared
HAI ¼ hospital associated infection
iAMA ¼ immobilized antimicrobial agent(s)
JIS ¼ Japanese Industry Standard
LbL ¼ layer by layer
LRV ¼ log reduction value
MAG ¼ magainin I
MBC ¼ minimum bactericidal concentration
MIC ¼ minimum inhibitory concentration
PAH ¼ polyallylamine hydrochloride
PEG ¼ polyethyleneglycol
PEI ¼ polyethyleneimine
PHMG ¼ polyhexamethyleneguanide
PMB ¼ polymyxin B
PSS ¼ polystyrene sulfonate
PVA ¼ polyvinylalcohol
PVC ¼ polyvinyl chloride
PVP ¼ polyvinylpyridinium
QA ¼ quaternary ammonium
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S. aureus ¼ Staphylococcus aureus
SEBS ¼ styrene ethylene butylene styrene
SEM ¼ scanning electron microscopy
Si-QAC ¼ (3-trimethoxysilyl) propyldimethyloctadecyl
ammonium chloride
VBNC ¼ viable but nonculturable
XPS ¼ x-ray photoelectron spectroscopy
ZOI ¼ zone of inhibition
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